Global Peri-implantitis Treatment Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
By Method Type;
Surgical Treatment, Mechanical Debridement, Laser Debridement, Open Flap Debridement, Open Flap Debridement With Guided Bone Generation, Non Surgical Treatment, Surface Debridement, Antibiotics ( Chlorhexidine Digluconate ), and Others.By End User;
Hospitals and Dental Clinics.By Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Peri-implantitis Treatment Market (USD Million), 2020 - 2030
In the year 2023, the Global Peri-implantitis Treatment Market was valued at USD 931.16 million. The size of this market is expected to increase to USD 1,669.68 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 8.7%.
Peri-implantitis is a pathological condition affecting the tissues surrounding dental implants, characterized by inflammation and the progressive loss of supporting bone. As dental implants have become an increasingly common solution for tooth replacement, the prevalence of peri-implantitis has also risen, leading to a growing demand for effective treatment solutions. The global peri-implantitis treatment market encompasses a range of products and procedures aimed at managing this condition, including mechanical debridement, antimicrobial treatments, surgical interventions, and regenerative procedures. This market is driven by the rising incidence of peri-implantitis, advancements in dental technology, and an increasing awareness of oral health.
The market is segmented based on treatment type, end-user, and geography. Treatment types include non-surgical and surgical therapies, each offering distinct approaches to managing peri-implantitis. Non-surgical treatments often involve mechanical cleaning and the use of antiseptics, while surgical options may include resective surgery, bone regeneration techniques, and the use of laser therapy. End-users of these treatments are primarily dental clinics, hospitals, and academic and research institutions, each playing a crucial role in the diagnosis and management of peri-implantitis. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and other regions, with varying degrees of market penetration and growth potential in each area.
North America and Europe currently dominate the global peri-implantitis treatment market, attributed to the high prevalence of dental implants and advanced healthcare infrastructure. These regions benefit from well-established dental care systems, high disposable incomes, and a strong focus on research and development in dental health. In contrast, the Asia-Pacific region is expected to witness significant growth in the coming years. This growth is driven by increasing dental tourism, rising healthcare expenditure, and a growing awareness of dental health. Additionally, the expanding middle-class population and improving healthcare facilities in countries like China and India contribute to the market's growth potential in this region.
The competitive landscape of the global peri-implantitis treatment market features a mix of established players and emerging companies. Leading companies are focusing on strategic initiatives such as mergers and acquisitions, product launches, and collaborations to strengthen their market position. Innovation is a key driver, with ongoing research aimed at developing more effective and less invasive treatment options. As the prevalence of peri-implantitis continues to rise, the market is poised for sustained growth, offering numerous opportunities for companies operating in this space to expand their product offerings and enhance patient outcomes.
Global Peri-implantitis Treatment Market Recent Developments & Report Snapshot
Recent Developments:
-
In July 2024, Fotona announced the opening of the Laser & Health (LA&HA) Academy Training Center in Malaysia. This new center is designed to support all Fotona users and practitioners, with the goal of enhancing knowledge, fostering collaboration, and promoting clinical excellence.
-
In February 2024, Straumann announced its complete acquisition of GalvoSurge, a Swiss medical device company specializing in dental implant care and maintenance solutions. GalvoSurge has developed an innovative approach for treating peri-implantitis.
Parameters | Description |
---|---|
Market | Global Peri-implantitis Treatment Market |
Study Period | 2020 - 2030 |
Base Year (for Peri-implantitis Treatment Market Size Estimates) | 2023 |
Drivers |
|
Restraints |
|
Opportunities |
|
Segment Analysis
The global peri-implantitis treatment market is anticipated to experience significant growth from 2024 to 2030, driven by an increasing prevalence of dental implants and rising awareness regarding oral health. The market is segmented by method type, including surgical treatments such as open flap debridement and guided bone regeneration, and non-surgical treatments like mechanical debridement and the use of antibiotics such as chlorhexidine digluconate. Among these, surgical treatments are expected to dominate due to their effectiveness in severe cases, while non-surgical treatments continue to gain traction for early-stage interventions.
End users in this market primarily include hospitals and dental clinics, with dental clinics likely to hold a larger market share owing to the specialized care they provide. The rising number of dental practitioners and advancements in dental care technologies further bolster the growth of this segment. Hospitals, however, are also witnessing increased demand, particularly for complex surgical procedures and in regions with advanced healthcare infrastructures.
Geographically, North America is projected to lead the market due to high healthcare spending, a large number of dental implant procedures, and the presence of major market players. Europe follows closely, supported by well-established dental care systems and growing awareness of peri-implantitis. The Asia Pacific region is expected to exhibit the highest growth rate, fueled by an expanding middle class, increased healthcare access, and rising dental tourism. Meanwhile, the markets in the Middle East and Africa, and Latin America are also set to grow steadily, driven by improving healthcare services and increasing adoption of advanced dental treatments.
Global Peri-implantitis Treatment Segment Analysis
In this report, the Global Peri-implantitis Treatment Market has been segmented by Method Type, End User and Geography.
Global Peri-implantitis Treatment Market, Segmentation by Method Type
The Global Peri-implantitis Treatment Market has been segmented by Method Type into Surgical Treatment, Mechanical Debridement, Laser Debridement, Open Flap Debridement, Open Flap Debridement with guided bone generation., Non Surgical Treatment, Surface Debridement, Antibiotics ( Chlorhexidine Digluconate ) and Others.
The Global Peri-implantitis Treatment Market is a dynamic sector encompassing various methods aimed at managing peri-implantitis, a condition characterized by inflammation around dental implants. The market is segmented by method type, which includes a range of surgical and non-surgical treatments. Surgical treatments are further categorized into Mechanical Debridement, Laser Debridement, Open Flap Debridement, and Open Flap Debridement with guided bone generation. These methods focus on physically removing the infected tissue and potentially regenerating lost bone to restore implant stability.
Non-surgical treatments in the market include Surface Debridement and the use of Antibiotics like Chlorhexidine Digluconate. These approaches aim to reduce bacterial load and inflammation without invasive procedures. Surface Debridement involves cleaning the implant surface, while Chlorhexidine Digluconate is employed for its antimicrobial properties. These methods are often chosen for their less invasive nature and lower risk of complications compared to surgical options.
Other treatments encompass a variety of innovative and adjunctive therapies designed to support the primary methods. These might include the use of photodynamic therapy, probiotics, and other novel antimicrobial agents. The market’s diverse segmentation reflects the multifaceted approach needed to address peri-implantitis effectively, considering the varying severity of the condition and patient-specific factors.
Global Peri-implantitis Treatment Market, Segmentation by End User
The Global Peri-implantitis Treatment Market has been segmented by End User into Hospitals and Dental Clinics.
The Global Peri-implantitis Treatment Market, a vital segment within dental healthcare, has been effectively segmented by end users into hospitals and dental clinics. This categorization helps in understanding the market dynamics and the distribution of peri-implantitis treatments. Hospitals, with their extensive resources and advanced medical infrastructure, often cater to more complex cases and severe infections that require multidisciplinary approaches. They are equipped with state-of-the-art facilities and a wide range of specialists, which can be crucial in managing peri-implantitis comprehensively.
Dental clinics play a pivotal role in the peri-implantitis treatment market by providing specialized and accessible care. These clinics, often led by experienced dental professionals, focus on preventive measures, early detection, and the management of peri-implant diseases. They are integral in maintaining oral health, offering routine check-ups, cleanings, and minor surgical interventions. Dental clinics usually provide a more personalized treatment approach, which can enhance patient satisfaction and compliance.
Both hospitals and dental clinics contribute significantly to the overall market for peri-implantitis treatments. While hospitals offer extensive care for advanced cases, dental clinics provide essential and accessible services that prevent the progression of peri-implantitis. This dual segmentation ensures that patients receive appropriate care tailored to the severity and specifics of their condition, ultimately enhancing treatment outcomes and promoting better oral health globally.
Global Peri-implantitis Treatment Market, Segmentation by Geography
In this report, the Global Peri-implantitis Treatment Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Peri-implantitis Treatment Market Share (%), by Geographical Region, 2023
In 2023, the global peri-implantitis treatment market showed significant regional variation in its distribution. Europe led the market, largely due to its advanced healthcare infrastructure, cutting-edge diagnostic tools, and a high concentration of skilled dental professionals. The region's robust healthcare systems and emphasis on technological innovation in dental care have solidified its dominance in this market.
North America also held a substantial share of the peri-implantitis treatment market, driven by the high prevalence of dental implants and a well-established healthcare sector. The availability of advanced treatments and a strong focus on research and development in dental care contributed to the region's significant market share. The presence of major pharmaceutical companies and a high level of awareness regarding peri-implantitis have further bolstered the market in North America.
The Asia-Pacific region is emerging as a key market for peri-implantitis treatment, with the highest growth rate projected for the coming years. This growth is attributed to increasing healthcare expenditure, rising awareness of dental health, and the expansion of dental care infrastructure. Countries like China, Japan, and India are seeing rapid advancements in dental technology and growing investments in healthcare, making Asia-Pacific a highly lucrative market for peri-implantitis treatment.
Market Trends
This report provides an in depth analysis of various factors that impact the dynamics of Global Peri-implantitis Treatment Market. These factors include; Market Drivers, Restraints and Opportunities Analysis.
Drivers, Restraints and Opportunity Analysis
Drivers
- Increasing prevalence of dental implants
- Rising awareness about oral health
-
Advances in dental technology - The Global Peri-implantitis Treatment Market is experiencing significant growth, driven by advances in dental technology and the increasing prevalence of peri-implant diseases. Peri-implantitis, a condition characterized by inflammation and bone loss around dental implants, poses a substantial challenge to dental professionals. With the rising adoption of dental implants worldwide, the demand for effective peri-implantitis treatments has surged. Cutting-edge technologies, such as laser therapy, antimicrobial photodynamic therapy, and advanced diagnostic tools, are playing a pivotal role in addressing this issue. These innovations not only enhance the accuracy of diagnosis but also improve treatment outcomes, making them crucial components in the fight against peri-implantitis.
Laser therapy has emerged as a particularly promising modality in the treatment of peri-implantitis. It offers a minimally invasive option that can effectively decontaminate implant surfaces and promote tissue regeneration. Various types of lasers, including diode and erbium lasers, are utilized to target and eliminate bacterial biofilms without causing damage to surrounding tissues. Additionally, antimicrobial photodynamic therapy, which combines photosensitizing agents with light to destroy harmful bacteria, is gaining traction due to its targeted approach and reduced risk of antibiotic resistance. These advanced therapies are reshaping the peri-implantitis treatment landscape, providing patients with more effective and less invasive options.
Advancements in diagnostic technologies are enhancing the early detection and management of peri-implantitis. Techniques such as cone-beam computed tomography (CBCT) and optical coherence tomography (OCT) offer detailed imaging capabilities, allowing for precise assessment of bone loss and peri-implant tissue health. These diagnostic tools enable clinicians to identify peri-implantitis at an earlier stage, facilitating timely intervention and better prognosis. As dental technology continues to evolve, the integration of these advanced diagnostic and therapeutic modalities is expected to drive the growth of the peri-implantitis treatment market, ultimately improving patient outcomes and the longevity of dental implants.
Restraints
- High cost of treatment
- Lack of skilled professionals
-
Limited insurance coverage - The global peri-implantitis treatment market is significantly influenced by the issue of limited insurance coverage, which poses a considerable barrier to patient access and market growth. Peri-implantitis, a condition characterized by inflammation around dental implants, requires specialized treatments that often include surgical and non-surgical interventions. These treatments can be costly, and in many regions, insurance coverage for dental procedures, especially those related to implants, is limited or non-existent. This lack of coverage leads to out-of-pocket expenses for patients, which can be prohibitively expensive and discourage many from seeking necessary care.
The limited insurance coverage not only impacts patients but also affects the growth potential of the peri-implantitis treatment market. Dental practitioners and clinics may see a reduction in the number of patients opting for these treatments due to financial constraints. Consequently, the demand for peri-implantitis treatment products and services remains lower than its potential. This financial barrier can stymie innovation and investment in the development of new treatment modalities and technologies, as companies may be hesitant to invest in a market with limited customer base expansion opportunities.
Addressing the issue of limited insurance coverage is crucial for the growth and accessibility of the peri-implantitis treatment market. Advocacy for broader insurance policies that include dental implant-related treatments could significantly enhance patient access to necessary care. Additionally, policy changes and the introduction of affordable insurance plans that cover peri-implantitis treatments can stimulate market demand, encouraging further innovation and competition among treatment providers. As insurance coverage improves, it is likely to lead to increased adoption of peri-implantitis treatments, benefiting patients and driving market growth.
Opportunities
- Growing aging population
- Increasing demand for cosmetic dentistry
-
Technological innovations in treatment methods - The global peri-implantitis treatment market is witnessing significant growth, driven by technological innovations aimed at improving treatment outcomes. One of the key advancements in this field is the development of laser therapy. Lasers, such as Er and CO2 lasers, are increasingly being used for the decontamination of implant surfaces and the removal of infected tissues. This method offers a minimally invasive approach, reducing patient discomfort and promoting faster healing. The precision of laser technology also allows for targeted treatment, preserving healthy surrounding tissues and enhancing overall treatment efficacy.
Another notable technological innovation is the use of photodynamic therapy (PDT). PDT involves the application of a photosensitizing agent that is activated by a specific wavelength of light, leading to the generation of reactive oxygen species that destroy pathogenic bacteria. This method has shown promise in effectively reducing microbial load without the use of antibiotics, thereby minimizing the risk of antibiotic resistance. Additionally, PDT can be combined with other treatments, such as mechanical debridement, to improve clinical outcomes. The integration of PDT into peri-implantitis treatment protocols represents a significant step forward in non-invasive and highly targeted therapeutic approaches.
The incorporation of regenerative techniques, such as the use of growth factors and biomaterials, is also transforming peri-implantitis treatment. Growth factors like platelet-rich plasma (PRP) and bone morphogenetic proteins (BMPs) are being utilized to promote tissue regeneration and enhance the stability of implants. Biomaterials, including biodegradable membranes and scaffolds, support bone and soft tissue regeneration by providing a conducive environment for cell growth. These regenerative strategies not only address the infection but also focus on restoring the structural integrity and function of the affected area, offering a comprehensive solution to peri-implantitis. The continuous evolution of these technologies underscores the commitment of the dental community to improving patient outcomes and advancing the standard of care in peri-implantitis treatment.
Competitive Landscape Analysis
Key players in Global Peri-implantitis Treatment Market include :
- Straumann Holding AG
- Nobel Biocare Services AG (Part of Danaher Corporation)
- Dentsply Sirona Inc.
- Zimmer Biomet Holdings, Inc.
- BioHorizons IPH, Inc. (Part of Henry Schein, Inc.)
- OraPharma, Inc. (Part of Bausch Health Companies Inc.)
- Sunstar Suisse S.A.
- GalvoSurge Dental AG
- MegaGen Implant Co., Ltd.
- Geistlich Pharma AG
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Method Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Global Peri-implantitis Treatment Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Increasing prevalence of dental implants
- Rising awareness about oral health
- Advances in dental technology
- Restraints
- High cost of treatment
- Lack of skilled professionals
- Limited insurance coverage
- Opportunities
- Growing aging population
- Increasing demand for cosmetic dentistry
- Technological innovations in treatment methods
- Drivers
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Competitive Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Peri-implantitis Treatment Market, By Method Type 2020 - 2030 (USD Million)
- Surgical Treatment
- Mechanical Debridement
- Laser Debridement
- Open Flap Debridement
- Open Flap Debridement with guided bone generation.
- Non Surgical Treatment
- Surface Debridement
- Antibiotics ( Chlorhexidine Digluconate )
- Others
- Surgical Treatment
- Global Peri-implantitis Treatment Market, By End User, 2020 - 2030 (USD Million)
- Hospitals
- Dental Clinics
- Global Peri-implantitis Treatment Market, By Geography, 2020 - 2030 (USD Million)
- North America
- United States
- Canada
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Nordic
- Benelux
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia & New Zealand
- South Korea
- ASEAN (Association of South East Asian Countries)
- Rest of Asia Pacific
- Middle East & Africa
- GCC
- Israel
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- North America
- Global Peri-implantitis Treatment Market, By Method Type 2020 - 2030 (USD Million)
- Competitive Landscape
- Company Profiles
- Straumann Holding AG
- Nobel Biocare Services AG (Part of Danaher Corporation)
- Dentsply Sirona Inc.
- Zimmer Biomet Holdings, Inc.
- BioHorizons IPH, Inc. (Part of Henry Schein, Inc.)
- OraPharma, Inc. (Part of Bausch Health Companies Inc.)
- Sunstar Suisse S.A.
- GalvoSurge Dental AG
- MegaGen Implant Co., Ltd.
- Geistlich Pharma AG
- Company Profiles
- Analyst Views
- Future Outlook of the Market